Literature DB >> 22853859

Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.

David Machado-Aranda1, Zhengdong Wang, Bi Yu, M V Suresh, Robert H Notter, Krishnan Raghavendran.   

Abstract

OBJECTIVE: Surfactant dysfunction is an important pathologic disturbance in various forms of acute inflammatory lung injury. Previously we reported the presence of marked alterations in the composition and activity of pulmonary surfactant in bilateral lung contusions (LC) injury induced by blunt trauma in rats. This is extended here to a mouse model of unilateral LC with a focus on compositional and functional changes in surfactant associated with permeability injury and increases in activity of secretory phospholipase A2.
RESULTS: Surfactant-associated gene expression was not altered in mice with unilateral LC injury on the basis of Affymetrix analysis. LC mice had significant permeability injury with increased albumin and total protein in bronchoalveolar lavage at 5, 24, 48, and 72 hours after insult compared with uninjured controls. The percent content of large surfactant aggregates was depleted at all postinjury times, and pulmonary pressure-volume (P-V) mechanics and compliance were abnormal during this period. Surfactant dysfunction was evaluated in 24 hours, when permeability injury and P-V changes were most prominent. At this time, activity levels of secretory phospholipase A2 were increased in bronchoalveolar lavage, and chromatographic analysis showed that large surfactant aggregates had decreased levels of phosphatidylcholine and increased levels of lyso-phosphatidylcholine. These changes were accompanied by severe detriments in large aggregate surface activity by pulsating bubble surfactometry. Large aggregates from LC mice at 24 hours had minimum surface tensions of only 12.6 ± 1.1 mN/m after prolonged bubble pulsation (20 min) compared with 0.7 ± 0.03 mN/m for uninjured controls.
CONCLUSION: These results document important detriments in the composition and activity of pulmonary surfactant in LC injury in mice and suggest that active synthetic phospholipase-resistant exogenous surfactants may have utility in treating surfactant dysfunction in this clinically important condition.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22853859      PMCID: PMC3509248          DOI: 10.1016/j.surg.2012.05.043

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  53 in total

1.  Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A₂ inhibition.

Authors:  Jessica A Yu; Miral R Sadaria; Xianzhong Meng; Sanchayita Mitra; Lihua Ao; David A Fullerton; Michael J Weyant
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02       Impact factor: 5.209

2.  Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.

Authors:  B A Holm; R H Notter
Journal:  J Appl Physiol (1985)       Date:  1987-10

3.  Pulsating bubble technique for evaluating pulmonary surfactant.

Authors:  G Enhorning
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-08

4.  Protein composition of rabbit alveolar surfactant subfractions.

Authors:  J R Wright; B J Benson; M C Williams; J Goerke; J A Clements
Journal:  Biochim Biophys Acta       Date:  1984-12-21

5.  Thoracic trauma.

Authors:  F R Lewis
Journal:  Surg Clin North Am       Date:  1982-02       Impact factor: 2.741

6.  Differential effects of manoalide on secreted and intracellular phospholipases.

Authors:  C F Bennett; S Mong; M A Clarke; L I Kruse; S T Crooke
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

7.  Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids.

Authors:  B A Holm; R H Notter; J N Finkelstein
Journal:  Chem Phys Lipids       Date:  1985-09       Impact factor: 3.329

8.  Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients.

Authors:  Miriam M Treggiari; Leonard D Hudson; Diane P Martin; Noel S Weiss; Ellen Caldwell; Gordon Rubenfeld
Journal:  Crit Care Med       Date:  2004-02       Impact factor: 7.598

9.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

Review 10.  SB-480848. GlaxoSmithKline.

Authors:  David P Rotella
Journal:  Curr Opin Investig Drugs       Date:  2004-03
View more
  14 in total

1.  Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α.

Authors:  Matthew A Sherman; Madathilparambil V Suresh; Vladislav A Dolgachev; Lane K McCandless; Xiang Xue; Li Ziru; David Machado-Aranda; Yatrik M Shah; Krishnan Raghavendran
Journal:  Ann Surg       Date:  2018-02       Impact factor: 12.969

2.  Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis.

Authors:  Carmen Priolo; Stéphane J H Ricoult; Damir Khabibullin; Harilaos Filippakis; Jane Yu; Brendan D Manning; Clary Clish; Elizabeth P Henske
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

3.  Inflammation product effects on dilatational mechanics can trigger the Laplace instability and acute respiratory distress syndrome.

Authors:  Sourav Barman; Michael L Davidson; Lynn M Walker; Shelly L Anna; Joseph A Zasadzinski
Journal:  Soft Matter       Date:  2020-07-29       Impact factor: 3.679

4.  N-Acetylcysteine counteracts oxidative stress and protects alveolar epithelial cells from lung contusion-induced apoptosis in rats with blunt chest trauma.

Authors:  Yeter Topcu-Tarladacalisir; Taner Tarladacalisir; Melike Sapmaz-Metin; Altemur Karamustafaoglu; Yesim Hulya Uz; Meryem Akpolat; Aysegul Cerkezkayabekir; Fatma Nesrin Turan
Journal:  J Mol Histol       Date:  2014-01-18       Impact factor: 2.611

Review 5.  Function of secreted phospholipase A2 group-X in asthma and allergic disease.

Authors:  James D Nolin; Ryan C Murphy; Michael H Gelb; William A Altemeier; William R Henderson; Teal S Hallstrand
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-12-05       Impact factor: 4.698

6.  Activation of hypoxia-inducible factor-1α in type 2 alveolar epithelial cell is a major driver of acute inflammation following lung contusion.

Authors:  Madathilparambil V Suresh; Sadeesh Kumar Ramakrishnan; Bivin Thomas; David Machado-Aranda; Yu Bi; Nicholas Talarico; Erik Anderson; Shah M Yatrik; Krishnan Raghavendran
Journal:  Crit Care Med       Date:  2014-10       Impact factor: 7.598

7.  Alveolar macrophage depletion increases the severity of acute inflammation following nonlethal unilateral lung contusion in mice.

Authors:  David Machado-Aranda; Madathilparambil V Suresh; Bi Yu; Vladislov Dolgachev; Mark R Hemmila; Krishnan Raghavendran
Journal:  J Trauma Acute Care Surg       Date:  2014-04       Impact factor: 3.313

8.  [The Use Of Pulmonary Gene Therapy In The Treatment Of Experimental Models Of Pneumonia And Septicemia].

Authors:  David Machado-Aranda
Journal:  Gac Med Caracas       Date:  2018-03

9.  Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities.

Authors:  Yong Tan; Dongmei Jia; Zhang Lin; Baosheng Guo; Bing He; Cheng Lu; Cheng Xiao; Zhongdi Liu; Ning Zhao; Zhaoxiang Bian; Ge Zhang; Weidong Zhang; Xinru Liu; Aiping Lu
Journal:  Int J Mol Sci       Date:  2016-07-16       Impact factor: 5.923

10.  Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia.

Authors:  Liang Cui; Dahai Zheng; Yie Hou Lee; Tze Khee Chan; Yadunanda Kumar; Wanxing Eugene Ho; Jian Zhu Chen; Steven R Tannenbaum; Choon Nam Ong
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.